{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:58:41Z","timestamp":1761897521443,"version":"3.41.2"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"uniQure biopharma B.V"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The preclinical development of microRNA-based gene therapies for inherited neurodegenerative diseases is accompanied by translational challenges. Due to the inaccessibility of the brain to periodically evaluate therapy effects, accessible and reliable biomarkers indicative of dosing, durability and therapeutic efficacy in the central nervous system are very much needed. This is particularly important for viral vector-based gene therapies, in which a one-time administration results in long-term expression of active therapeutic molecules in the brain. Recently, extracellular vesicles have been identified as carriers of RNA species, including microRNAs, and proteins in all biological fluids, whilst becoming potential sources of biomarkers for diagnosis. In this study, we investigated the secretion and potential use of circulating miRNAs associated with extracellular vesicles as suitable sources to monitor the expression and durability of gene therapies in the brain. Neuronal cells derived from induced pluripotent stem cells were treated with adeno-associated viral vector serotype 5 carrying an engineered microRNA targeting huntingtin or ataxin3 gene sequences, the diseases-causing genes of Huntington disease and spinocerebellar ataxia type 3, respectively. After treatment, the secretion of mature engineered microRNA molecules was confirmed, with extracellular microRNA levels correlating with viral dose and cellular microRNA expression in neurons. We further investigated the detection of engineered microRNAs over time in the CSF of non-human primates after a single intrastriatal injection of adeno-associated viral vector serotype 5 carrying a huntingtin-targeting engineered microRNA. Quantifiable engineered microRNA levels enriched in extracellular vesicles were detected in the CSF up to two years after brain infusion. Altogether, these results confirm the long-term expression of adeno-associated viral vector serotype 5-delivered microRNAs and support the use of extracellular vesicle-associated microRNAs as novel translational pharmacokinetic markers in ongoing clinical trials of gene therapies for neurodegenerative diseases.<\/jats:p>","DOI":"10.1093\/braincomms\/fcab054","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T19:14:46Z","timestamp":1617218086000},"source":"Crossref","is-referenced-by-count":5,"title":["Secreted therapeutics: monitoring durability of microRNA-based gene therapies in the central nervous system"],"prefix":"10.1093","volume":"3","author":[{"given":"Marina","family":"Sogorb-Gonzalez","sequence":"first","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"},{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Vendrell-Tornero","sequence":"additional","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanda","family":"Snapper","sequence":"additional","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anouk","family":"Stam","sequence":"additional","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonay","family":"Keskin","sequence":"additional","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Miniarikova","sequence":"additional","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"},{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth A","family":"Spronck","sequence":"additional","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"de Haan","sequence":"additional","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rienk","family":"Nieuwland","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Clinical Chemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands, and Vesicles Observation Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavlina","family":"Konstantinova","sequence":"additional","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander J","family":"van Deventer1","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin M","family":"Evers","sequence":"additional","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Vall\u00e8s","sequence":"additional","affiliation":[{"name":"Department of Research & Development, uniQure Biopharma N.V, ., Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"2021070810510030900_fcab054-B1","first-page":"395","volume-title":"Advances in experimental medicine and biology","author":"Matos","year":"2018"},{"issue":"10","key":"2021070810510030900_fcab054-B2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington\u2019s disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol"},{"issue":"R1","key":"2021070810510030900_fcab054-B3","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1093\/hmg\/ddv442","article-title":"Gene suppression strategies for dominantly inherited neurodegenerative diseases: Lessons from Huntington\u2019s disease and spinocerebellar ataxia","volume":"25","author":"Keiser","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"R1","key":"2021070810510030900_fcab054-B4","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddr137","article-title":"RNAi medicine for the brain: Progresses and challenges","volume":"20","author":"Boudreau","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2021070810510030900_fcab054-B5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ymthe.2018.02.002","article-title":"Translation of MicroRNA-based Huntingtin-Lowering therapies from preclinical studies to the clinic","volume":"26","author":"Miniarikova","year":"2018","journal-title":"Mol Ther"},{"issue":"5","key":"2021070810510030900_fcab054-B6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in Huntington\u2019s disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"issue":"7","key":"2021070810510030900_fcab054-B7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat Rev Genet"},{"issue":"3","key":"2021070810510030900_fcab054-B8","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1038\/mtna.2016.7","article-title":"Design, characterization, and lead selection of therapeutic miRNAs targeting huntingtin for development of gene therapy for Huntington\u2019s disease","volume":"5","author":"Miniarikova","year":"2016","journal-title":"Mol Ther - Nucleic Acids"},{"issue":"12","key":"2021070810510030900_fcab054-B9","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington\u2019s disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol Ther"},{"key":"2021070810510030900_fcab054-B10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.omtm.2019.10.008","article-title":"Development of an AAV-based MicroRNA gene therapy to treat Machado-Joseph disease","volume":"15","author":"Martier","year":"2019","journal-title":"Mol Ther - Methods Clin Dev"},{"issue":"10","key":"2021070810510030900_fcab054-B11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gt.2017.71","article-title":"AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington\u2019s disease","volume":"24","author":"Miniarikova","year":"2017","journal-title":"Gene Ther"},{"issue":"9","key":"2021070810510030900_fcab054-B12","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ymthe.2018.06.021","article-title":"AAV5-miHTT gene therapy demonstrates broad distribution and strong human mutant Huntingtin lowering in a Huntington\u2019s disease minipig model","volume":"26","author":"Evers","year":"2018","journal-title":"Mol Ther"},{"key":"2021070810510030900_fcab054-B13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.omtm.2019.03.002","article-title":"AAV5-miHTT gene therapy demonstrates sustained Huntingtin lowering and functional improvement in Huntington disease mouse models","volume":"13","author":"Spronck","year":"2019","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"2021070810510030900_fcab054-B14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: Moving from bench to clinic as next generation medicine","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Mol Ther - Nucleic Acids"},{"issue":"7","key":"2021070810510030900_fcab054-B15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1089\/hum.2016.087","article-title":"Adeno-associated virus-based gene therapy for CNS diseases","volume":"27","author":"Hocquemiller","year":"2016","journal-title":"Hum Gene Ther"},{"issue":"4","key":"2021070810510030900_fcab054-B16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/gt.2017.14","article-title":"MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain","volume":"24","author":"Samaranch","year":"2017","journal-title":"Gene Ther"},{"key":"2021070810510030900_fcab054-B17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/7854_2014_354","article-title":"The neuropathology of Huntington\u2019s disease","volume":"22","author":"Waldvogel","year":"2015","journal-title":"Curr Top Behav Neurosci"},{"issue":"6","key":"2021070810510030900_fcab054-B18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2021070810510030900_fcab054-B19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","article-title":"Exosome and exosomal MicroRNA\u202f: Trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Genomics, Proteomics Bioinforma"},{"issue":"1","key":"2021070810510030900_fcab054-B20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13195-017-0316-0","article-title":"Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases","volume":"9","author":"Sheinerman","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2021070810510030900_fcab054-B21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jhg.2016.87","article-title":"MicroRNAs in extracellular vesicles: Potential cancer biomarkers","volume":"62","author":"Kinoshita","year":"2017","journal-title":"J Hum Genet"},{"issue":"1","key":"2021070810510030900_fcab054-B22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"J Alzheimers Dis"},{"issue":"35","key":"2021070810510030900_fcab054-B23","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease","volume":"6","author":"Gui","year":"2015","journal-title":"Oncotarget"},{"issue":"22","key":"2021070810510030900_fcab054-B24","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1212\/WNL.0b013e3182759621","article-title":"Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study","volume":"79","author":"Haghikia","year":"2012","journal-title":"Neurology"},{"key":"2021070810510030900_fcab054-B25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2164-13-357","article-title":"Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types","volume":"13","author":"Guduric-Fuchs","year":"2012","journal-title":"BMC Genomics"},{"issue":"1","key":"2021070810510030900_fcab054-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3402\/jev.v3.23430","article-title":"Single-step isolation of extracellular vesicles by size-exclusion chromatography","volume":"3","author":"B\u00f6ing","year":"2014","journal-title":"J Extracell Vesicles"},{"issue":"7298","key":"2021070810510030900_fcab054-B27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature09092","article-title":"A dicer-independent miRNA biogenesis pathway that requires Ago catalysis","volume":"465","author":"Cheloufi","year":"2010","journal-title":"Nature"},{"issue":"1","key":"2021070810510030900_fcab054-B28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010132","article-title":"Systems and synthetic microRNA biology: From biogenesis to disease pathogenesis","volume":"21","author":"Matsuyama","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2021070810510030900_fcab054-B29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.omtm.2019.09.010","article-title":"AAV5-miHTT lowers Huntingtin mRNA and protein without off-target effects in patient-derived neuronal cultures and astrocytes","volume":"15","author":"Keskin","year":"2019","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"2021070810510030900_fcab054-B30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.omtm.2020.05.028","article-title":"Cerebral organoids: A human model for AAV capsid selection and therapeutic transgene efficacy in the brain","volume":"18","author":"Depla","year":"2020","journal-title":"Mol Ther - Methods Clin Dev"},{"issue":"1","key":"2021070810510030900_fcab054-B31","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1555410","article-title":"Precipitation-based extracellular vesicle isolation from rat plasma co-precipitate vesicle-free microRNAs","volume":"8","author":"Karttunen","year":"2019","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"2021070810510030900_fcab054-B32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1373\/clinchem.2017.278978","article-title":"Comparison of generic fluorescent markers for detection of extracellular vesicles by flow cytometry","volume":"64","author":"De Rond","year":"2018","journal-title":"Clin Chem"},{"issue":"1","key":"2021070810510030900_fcab054-B33","doi-asserted-by":"crossref","first-page":"1643671","DOI":"10.1080\/20013078.2019.1643671","article-title":"Refractive index to evaluate staining specificity of extracellular vesicles by flow cytometry","volume":"8","author":"de Rond","year":"2019","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"2021070810510030900_fcab054-B34","doi-asserted-by":"crossref","first-page":"e0136133-19","DOI":"10.1371\/journal.pone.0136133","article-title":"Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method","volume":"10","author":"Enderle","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"2021070810510030900_fcab054-B35","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The glymphatic system: A beginner\u2019s guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem Res"},{"issue":"1","key":"2021070810510030900_fcab054-B36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-019-0338-0","article-title":"Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3","volume":"14","author":"Li","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"2","key":"2021070810510030900_fcab054-B37","doi-asserted-by":"crossref","first-page":"e0172762","DOI":"10.1371\/journal.pone.0172762","article-title":"Tau or neurofilament light-Which is the more suitable biomarker for Huntington\u2019s disease?","volume":"12","author":"Niemel\u00e4","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"2021070810510030900_fcab054-B38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/1471-2164-14-319","article-title":"Characterization of human plasma-derived exosomal RNAs by deep sequencing","volume":"14","author":"Huang","year":"2013","journal-title":"BMC Genomics"},{"key":"2021070810510030900_fcab054-B39","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/ncomms3980","article-title":"Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs","volume":"4","author":"Villarroya-Beltri","year":"2013","journal-title":"Nat Commun"},{"issue":"6","key":"2021070810510030900_fcab054-B40","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.celrep.2014.08.027","article-title":"Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes","volume":"8","author":"Koppers-Lalic","year":"2014","journal-title":"Cell Rep"},{"issue":"1","key":"2021070810510030900_fcab054-B41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1534\/g3.116.036137","article-title":"Small RNA sequencing in cells and exosomes identifies eQTLs and 14q32 as a region of active export","volume":"7","author":"Tsang","year":"2017","journal-title":"G3 Genes, Genomes, Genet"},{"issue":"5","key":"2021070810510030900_fcab054-B42","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.celrep.2014.07.035","article-title":"Endogenous RNAs modulate MicroRNA sorting to exosomes and transfer to acceptor cells","volume":"8","author":"Squadrito","year":"2014","journal-title":"Cell Rep"},{"issue":"18","key":"2021070810510030900_fcab054-B43","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1093\/nar\/gkx779","article-title":"Survey and summary: Dicer-independent processing of small RNA duplexes: Mechanistic insights and applications","volume":"45","author":"Herrera-Carrillo","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2021070810510030900_fcab054-B44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41551-019-0502-4","article-title":"Reduction of the therapeutic dose of silencing RNA by packaging it in extracellular vesicles via a pre-microRNA backbone","volume":"4","author":"Reshke","year":"2020","journal-title":"Nat Biomed Eng"},{"issue":"11","key":"2021070810510030900_fcab054-B45","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/14789450.2018.1537788","article-title":"Understanding extracellular vesicle diversity\u2013current status","volume":"15","author":"Greening","year":"2018","journal-title":"Expert Rev Proteomics"},{"issue":"1","key":"2021070810510030900_fcab054-B46","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"2021070810510030900_fcab054-B47","doi-asserted-by":"crossref","first-page":"8545347","DOI":"10.1155\/2018\/8545347","article-title":"Isolation of Extracellular Vesicles: General Methodologies and Latest Trends","volume":"2018","author":"Konoshenko","year":"2018","journal-title":"Biomed Res Int"},{"issue":"10","key":"2021070810510030900_fcab054-B48","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/CIRCRESAHA.117.309417","article-title":"Methodological guidelines to study extracellular vesicles","volume":"120","author":"Coumans","year":"2017","journal-title":"Circ Res"},{"issue":"16","key":"2021070810510030900_fcab054-B49","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2021070810510030900_fcab054-B50","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2021070810510030900_fcab054-B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-017-1374-6","article-title":"Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma","volume":"16","author":"Stranska","year":"2018","journal-title":"J Transl Med"},{"issue":"6","key":"2021070810510030900_fcab054-B52","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/brain\/awaa110","article-title":"Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction","volume":"143","author":"Zhenwei","year":"2020","journal-title":"Brain"},{"issue":"14","key":"2021070810510030900_fcab054-B53","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1073\/pnas.0914843107","article-title":"Functional delivery of viral miRNAs via exosomes","volume":"107","author":"Pegtel","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2021070810510030900_fcab054-B54","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/nprot.2012.131","article-title":"Exosome-mediated delivery of siRNA in vitro and in vivo","volume":"7","author":"El-Andaloussi","year":"2012","journal-title":"Nat Protoc"},{"issue":"1","key":"2021070810510030900_fcab054-B55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat Cell Biol"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcab054\/36854160\/fcab054.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/3\/2\/fcab054\/41723508\/fcab054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/3\/2\/fcab054\/41723508\/fcab054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T12:04:58Z","timestamp":1698840298000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcab054\/6207984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4,5]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcab054","relation":{},"ISSN":["2632-1297"],"issn-type":[{"type":"electronic","value":"2632-1297"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2021,4,1]]},"article-number":"fcab054"}}